Lv5
880 积分 2024-10-18 加入
HJM-561, a Potent, Selective, and Orally Bioavailable EGFR PROTAC that Overcomes Osimertinib-Resistant EGFR Triple Mutations
5个月前
已完结
Quantitative reactivity profiling predicts functional cysteines in proteomes
6个月前
已完结
A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2
7个月前
已完结
Molecular glue degraders: exciting opportunities for novel drug discovery
8个月前
已完结
Discovery of a molecular glue for EGFR degradation
8个月前
已完结
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
9个月前
已完结
Impact of Antifibrotic Therapy on Mortality and Acute Exacerbation in Idiopathic Pulmonary Fibrosis
9个月前
已完结
Idiopathic pulmonary fibrosis
9个月前
已关闭